Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 437
Aptamer sequence: CAGGCAUGCCUAGCUAAGCAGCCCAUGGCUUAUGCGCGGAAUAUUGGCUUCCGUUC
Target unique ID: Q04609
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_431 A10-3 Protein FOLH1_HUMAN 20.5 nM HEPES buffered saline (pH 7.4), 1 mM MgCl2, 1 mM CaCl2, 0.01% I-block (Tropix Inc. Bedford, MA), and 0.05% Tween 20 12124337
Structure information of aptamer
Aptamer Sequence: CAGGCAUGCCUAGCUAAGCAGCCCAUGGCUUAUGCGCGGAAUAUUGGCUUCCGUUC
The optimal secondary structure in dot-bracket notation: ...(((((((..(((....)))....)))..))))((((((.......))))))..
The centroid secondary structure in dot-bracket notation: ...(((((((..(((....)))....)))..))))((((((.......))))))..
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_431 Description A10-3
Aptamer chemistry RNA Length 56 nt
GC content 55.4% Molecular weight 17,906.61 Da
Molarity of 1 μg/μl solution 55.85 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence CAGGCAUGCCUAGCUAAGCAGCCCAUGGCUUAUGCGCGGAAUAUUGGCUUCCGUUC
Applications Be used clinically as NAALADase inhibitors or be modified to carry imaging agents and therapeutic agents directed to prostate cancer cells
Target information
Type Detail Type Detail
Uniprot ID Q04609 Protein name Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)
Gene name(s) FOLH1 FOLH NAALAD1 PSM PSMA GIG27 Organism Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)
Status reviewed in uniprot database Length 750
Mass 84,331 Activity regulation The NAALADase activity is inhibited by beta-NAAG, quisqualic acid, 2-(phosphonomethyl) pentanedioic acid (PMPA) and EDTA
Involvement in disease N/A Catalytic activity Reaction=Release of an unsubstituted, C-terminal glutamyl residue, typically from Ac-Asp-Glu or folylpoly-gamma-glutamates
PDB ID(s)
1Z8L;2C6C;2C6G;2C6P;2CIJ;2JBJ;2JBK;2OOT;2OR4;2PVV;2PVW;2XEF;2XEG;2XEI;2XEJ;3BHX;3BI0;3BI1;3BXM;3D7D;3D7F;3D7G;3D7H;3IWW;3RBU;3SJE;3SJF;3SJG;3SJX;4JYW;4JZ0;4LQG;4MCP;4MCQ;4MCR;4MCS;4NGM;4NGN;4NGP;4NGQ;4NGR;4NGS;4NGT;4OC0;4OC1;4OC2;4OC3;4OC4;4OC5;4OME;4P44;4P45;4P4B;4P4D;4P4E;4P4F;4P4I;4P4J;4W9Y;4X3R;5D29;5ELY;5F09;5O5R;5O5T;5O5U;5OF0;6ETY;6EZ9;6F5L;6FE5;6H7Y;6H7Z;6HKJ;6HKZ;6RBC;6RTI;6S1X;6SGP;6SKH;7BFZ;
Function Has both folate hydrolase and N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity.
Activity data

No relevant experimental diagram

Interaction ID 437
Target type Protein
Target unique ID Q04609
Activity 20.5 nM
Binding Conditions/Buffer

HEPES buffered saline (pH 7.4), 1 mM MgCl2, 1 mM CaCl2, 0.01% I-block (Tropix Inc. Bedford, MA), and 0.05% Tween 20

Assay

N/A

PubMed ID 12124337
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_256 RNA GGGCGCUAAGUCCUCGCUCAUGCGCGUCCCAUGGGGUAUAGAGGGGUCGAAGUGGACGCGCGACUCGGAUCCU 54.79%
Apta_305 RNA GGGAGGACGAUGCGGAUCGCCCUGAACCGGCCCAGCAGACUGCUGACGGCACGAUCCGCAUCGUCCUCCC 54.29%
Apta_170 RNA GGGAGACAAGACUAGACGCUCAAUGUGGGCCACGCCCGAUUUUACGCUUUUACCCGCACGCGAUUGGUUUGUUUCCC 51.95%
Apta_353 RNA GAAUUCCGCGUGUGCCAGCGAAAGUUGCGUAUGGGUCACAUCGCAGGCACAUGUCAUCUGGGCGGUCCGUUCGGGAUCC 51.90%
Apta_1 RNA ACGAAGCUUGAUCCCGUUUGCCGGUCGAUCGCUUCGA 51.79%
Apta_243 RNA GCUUGAAGCUAGCAGUAAGACUAGCGCUACGGAUGGGUGUGCG 51.79%
Apta_244 RNA GCUUCCGGAGAGAAGGGUCAAAGUUGUGCGGGAGUGUGUUGUGG 51.79%
Apta_632 RNA GACGAGAAGGAGUGCUGGUUAUACUAGCGGUUAGGUCACUCGUC 51.79%
Apta_703 RNA GGGCGGAUGAGACGCUUGGCGUGUGCUGUGGAGAGUCAUCCG 51.79%
Apta_52 RNA ACUGUCCUCCCUUCAGAGAGCGCGGGACCCUUAACUUGGGGCCCACGAACAGCUUCAGUUCCGUCUCGGCGU 51.39%
Apta_1057 RNA UCUGAGGGGUUGGGGCCGCAGUCUCGUCGCCAUGGCUAACGAGGCCGGAACUAGUUUUAGCCGAAAUGAUCGAUGC 51.32%
Apta_55 RNA GACAUCUGUAAGUAAGAUUCUAUCUGCAAAGCGGUUAGGAGGGCUCGGACUCUGAUUGCCUCCCCGCACC 50.00%
Apta_304 RNA CGGCCGAUAGAAAGACUACUUGAGCCCUUAAAUGAGGUUAUGUGCGGCCG 50.00%
Apta_365 RNA GGACCUAUGCAGUAGCCAGUGUGGACUGGGCUGCCCCCCC 50.00%
Apta_367 RNA CGAGCGUAGAAUGUCUUCCCACUAGACGUCGUUCGGCCCC 50.00%
Apta_575 RNA AGAGCUUGACGGUCCCGAGAGUCGAGCCCAAGCUGACACUGGACCUUUGCGGACCACGUGUUGAUCGUCG 50.00%
Apta_647 RNA GGAUCCCGACUGGCGAGAGCCAGGUAACGAAUGGAUCC 50.00%
Apta_816 RNA GGGUUCACUGCAGACUUGACGAAGCUUGAGAGAUGCCCCCUGAUGUGCAUUCUUGUUGUGUUGCGGCAAUGGAUCCACAUCUACGAAUUC 50.00%
Apta_849 RNA UCCCGAUUACUGUACAUACCUUAGCCCAUAGCUGGCUGC 50.00%
Apta_859 RNA GGGAGUCUGAAGUCGGACUUGUUAUCAAUUCACUUCAGACU 50.00%